Exchange: NASDAQ·Updated 05:17 PM EDT
REPL logo

REPL Replimune Group Inc

$15.98
$0.31
(1.98%)
Today
Closed $15.98
$0.00
(0.00%)
After Hours
Reported EarningsAug 14
Mkt Cap$1.48B
Vol1.99M

About REPL

Replimune Group, Inc. is a clinical-stage biotechnology company. It engages in the business of developing oncolytic immunotherapies for the treatment of cancer. The company was founded by Philip Astley-Sparke, Colin A. Love, and Robert Coffin in March 2015 and is headquartered in Woburn, MA.
67

Bullish Sentiment

How do you feel about REPL?

Advertisement|Remove ads.